Given recent discoveries of the presence of lncRNAs relevant to neuroblastoma [40, 41] and various reports of the significance of GAS5 in several cancer systems [8–10], we decided to examine if this lncRNA showed promise as a biomarker or possible therapeutic target in this cancer system. Here, GAS5 is linked to cancer.